Where does CureVac AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CureVac AG ranks #3,699 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CureVac AG hold?

CureVac AG holds 98 US utility patents granted between 2015 and 2022, spanning 13 technology areas.

What is CureVac AG's Innovation Score?

CureVac AG has an Innovation Score of 44.1 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CureVac AG focus on?

CureVac AG's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 89 patents, ranking #218 of 7,163 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is CureVac AG's patent grant rate increasing or decreasing?

CureVac AG's recent grant velocity is +9% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for CureVac AG's patents?

CureVac AG's patents average 20.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CureVac AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CureVac AG

USPTO PatentsView assignee record - 98 granted patents across 13 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Curevac ranks #3,699 of 49,997 tracked US assignees by granted-patent volume, with 98 patents across 13 technology areas.

#3,699
of 49,997 US assignees by volume: Top 27%
by Innovation Score (44.1/100): 20.3
avg claims per patent: +9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3699 · Foreign Corporation #3,699 · 98 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 98 grants
TOP-DECILE #3,699/49,997
PHOTO-FINISH Adient Luxembourg…
CPC-FOCUS A61K · 13 areas
INNOV-PAR 44.1/100
CLAIMS-DENSE 20.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adient Luxembourg Holding S.a.r.l. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Curevac’s 44.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.9 pts (36%) Velocity 3.3 pts (7%) Breadth 12.7 pts (29%) Claim depth 12.2 pts (28%)

Qualcomm Incorporated · highest

85
Ambiq Micro · near

44
CureVac · this assignee

44
Enanta Pharmaceuticals · near

44
Hutchison Medipharma · near

44
Qualys · near

44
3D Lighting… · lowest

7

What this shows Curevac's Innovation Score is 44.1/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Curevac?

Each dot is one of Curevac’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curevac’s own 20.3 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Curevac vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Curevac's grants concentrate

CureVac AG is a focused PatentsView assignee: 13 CPC subclasses with 90.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (21 grants) versus a trough of 2 in 2015. By volume, Curevac sits between Aichi Steel Corporation and Igus GMBH.

Curevac's three-year grant acceleration

From 2019–2021 to 2022–2024, CureVac AG moved from 43 to 21 grants (0.49x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Aichi Steel

98
Adient Luxembourg…

98
Biosense Webster

98
CTS

98
Delta T

98
Flir Systems AB

98
Hirata

98
Igus

98
Curevac ◀

98

What this shows CureVac holds 98 patents at rank #3,699, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CureVac

By rank, the assignees closest to #3,699 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in CureVac's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CureVac, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), CureVac ranks #218 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Enanta Pharmaceuticals, Inc. 44 Ambiq Micro, Inc. 44 Qualys, Inc. 44 Hutchison Medipharma Limited 44

Similar claim depth

Nearest assignees by average claims per patent (20.3 here).

Proxense, LLC 20.3 avg Sony Interactive Entertainment America LLC 20.3 avg Spirent Communications, Inc. 20.3 avg Joy Global Surface Mining Inc 20.3 avg

Curevac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CureVac AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	2.0%
2016	11	11.2%
2017	10	10.2%
2018	11	11.2%
2019	13	13.3%
2020	15	15.3%
2021	15	15.3%
2022	21	21.4%

Which technologies does CureVac AG patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 89

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 79

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 67

C07K - Peptides 41

Y02A - Technologies FOR Adaptation TO Climate Change 35

C12Y - Enzymes 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07C - Acyclic OR Carbocyclic Compounds 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CureVac AG's patent record in context - here's where to go next.

CureVac AG's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90.8% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,699 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CureVac AG against Aichi Steel Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.